Leuxa Depot 22.5 mg Injection 1's Substitute
RXBDR Pharmaceuticals Internationals Pvt Ltd
₹13095
(₹10737.9 per unit)
RXIpca Laboratories Ltd
₹12047.5
(₹12047.5 per unit)
RXZydus Cadila
₹16993
(₹13934.3 per unit)
RXSamarth Life Sciences Pvt Ltd
₹18246.5
(₹14962.1 per unit)
RXAxiommax Oncology Pvt Ltd
₹18225
(₹18225.0 per unit)
RXEris Life Sciences Ltd
₹18500
(₹18500.0 per unit)
RXBAJAJ HEALTHCARE LTD
₹18990
(₹18990.0 per unit)
RXRanbaxy Laboratories Ltd
₹24892
(₹20411.44 per unit)
Patients may explore substitutes in the following scenarios:
Before you switch from Leuxa Depot 22.5 mg Injection 1's to another medicine, here are some important points to keep in mind:
Same salt, different brands:
Most substitutes contain the same active ingredient - LEUPRORELIN-22.5MG, but the fillers, coating, or manufacturing quality may vary slightly.
Consult your doctor first:
Even if the salt is the same, your doctor can confirm if the substitute is right for your condition, dosage, and health history.
Watch out for allergies or reactions:
Some people may react differently to certain brands due to inactive ingredients. If you notice any side effects, inform your doctor immediately.
Price ≠ effectiveness:
A lower-priced substitute doesn't mean it's less effective. Many generic medicines work just as well as branded ones.
Check the dosage form and strength:
Always match the substitute’s strength (e.g., 5mg, 10mg) and form (tablet, capsule, syrup) with what your doctor prescribed.
Leuxa Depot 22.5 mg Injection 1's is used in the treatment of prostate cancer, breast cancer, endometriosis, and premature puberty. The detailed uses of Leuxa Depot 22.5 mg Injection 1's are as follows:
Leuxa Depot 22.5 mg Injection 1's contains Leuprorelin which works similarly to the natural hormone, gonadotropin-releasing hormone (GnRH), by acting on the pituitary gland and decreasing the levels of testosterone in men and oestrogen in women. Thereby, Leuxa Depot 22.5 mg Injection 1's is used in the treatment of prostate cancer by inhibiting the growth of the tumour or causing it to shrink. Also, Leuxa Depot 22.5 mg Injection 1's is used to treat hormone-responsive breast cancer in pre and postmenopausal women. By reducing testosterone and oestrogen levels, Leuxa Depot 22.5 mg Injection 1's delays the onset of puberty in children.
The substitutes of Leuxa Depot 22.5 mg Injection 1's contain the same active salt(s) - LEUPRORELIN-22.5MG. However, they may differ in price, manufacturing quality, and inactive ingredients. Speak to your doctor to find a suitable option.
Switching to a generic substitute medicine in the place of Leuxa Depot 22.5 mg Injection 1's is often possible if it has the same salt, strength, and dosage form. But always check with your doctor before making any changes to your medication.
Generics versions of Leuxa Depot 22.5 mg Injection 1's are typically more affordable because they don’t include the original brand's research, development, and marketing costs. They contain the same active ingredient and are approved for safety and effectiveness.
Most people don’t notice any difference. However, some may react to different fillers or coatings. If you notice any unusual symptoms after switching, consult your doctor.
Make sure the new medicine has the same active salt, strength, dosage form. Always confirm the change with your doctor or pharmacist.
Substitutes of Leuxa Depot 22.5 mg Injection 1's meet the same safety and efficacy standards as Leuxa Depot 22.5 mg Injection 1's, but small differences in absorption or formulation can exist. A doctor can help you choose the right one for your needs.
Yes. Substitutes of Leuxa Depot 22.5 mg Injection 1's may vary in color, size, or shape due to differences in manufacturing and branding, but this does not affect how they work.
Yes, it’s generally safe to switch between multiple substitutes of Leuxa Depot 22.5 mg Injection 1's if they have the same salt and strength. However, always inform your doctor so they can monitor how your body responds.
Yes, many people safely use substitutes of Leuxa Depot 22.5 mg Injection 1's for long-term treatment. Just ensure it’s done under medical supervision.
If your symptoms stay under control or lab results remain stable, the substitute for Leuxa Depot 22.5 mg Injection 1's is likely working well. Regular follow-ups with your doctor are important.
Absolutely. Even with the same salt, small differences can affect how your body responds when switching from Leuxa Depot 22.5 mg Injection 1's to its substitute. Always consult your doctor before switching.
Leuxa Depot 22.5 mg Injection 1's contains Leuprorelin, a synthetic hormone that works similar to the natural hormone, gonadotropin-releasing hormone (GnRH) by acting on the pituitary gland and decreases the levels of testosterone in men and oestrogen in women. Thereby, Leuxa Depot 22.5 mg Injection 1's is used in the treatment of prostate cancer by inhibiting the growth of tumour or causing it to shrink.
Leuxa Depot 22.5 mg Injection 1's may stop menstrual periods. However, after 7 to 12 weeks of taking the final dose of injection, periods will resume. Please consult a doctor if you have any concerns regarding this.
Leuxa Depot 22.5 mg Injection 1's should be used with caution in diabetic patients as it may increase the risk of high blood sugar levels. Therefore, it is advised to regularly monitor blood sugar levels while taking Leuxa Depot 22.5 mg Injection 1's and inform your doctor if you have diabetes before taking Leuxa Depot 22.5 mg Injection 1's.
Leuxa Depot 22.5 mg Injection 1's may be used to treat endometriosis (tissue lining the uterus known as endometrium grows outside the uterus). Leuxa Depot 22.5 mg Injection 1's reduces oestrogen levels and causes menopause temporarily. Thereby, shrink the tissue outside the uterus or stop its growth.
Leuxa Depot 22.5 mg Injection 1's may decrease bone density, especially when used for the treatment of premature puberty in children. Therefore, regular monitoring of bone density is recommended while taking Leuxa Depot 22.5 mg Injection 1's.
Leuxa Depot 22.5 mg Injection 1's should be used with extreme caution in patients suffering from depression as it may worsen the condition. Therefore, inform your doctor if you have any history of depression before taking Leuxa Depot 22.5 mg Injection 1's.
No, Leuxa Depot 22.5 mg Injection 1's is not a chemotherapy medicine. It is a synthetic hormone which belongs to the class of medicines called gonadotropin-releasing hormone (GnRH) agonists.
Yes, Leuxa Depot 22.5 mg Injection 1's is a hormonal medicine that works by altering reproductive hormones. It is not recommended for use during pregnancy as it can harm the fetus and may lead to abortion. If you are pregnant or planning to become pregnant, please inform your doctor.
The common side effects of Leuxa Depot 22.5 mg Injection 1's are pain, redness, swelling, or skin hardening at the injection site, muscle weakness, bone pain, inability to have an erection, breast tenderness, headache, vaginal dryness, changes in breast size, acne, or mood swings. If any of these side effects persist or worsen, please consult your doctor.
Leuxa Depot 22.5 mg Injection 1's belongs to the class of synthetic hormones used in the treatment of prostate cancer in men, endometriosis, and hormone-responsive breast cancer in women. Also, it is used to treat premature puberty in children.